against-the-disease
AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ
December 12, 2015 by publisher · Leave a Comment
Netherlands based-Acerta is developing cancer drugs that use the body's own defenses against the disease. On Monday, Acerta reported that 95 percent of patients with chronic lymphocytic leukemia positively responded to
Read the rest here:
AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ